Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Marian Gindy is Executive Director, Discovery Pharmaceutical Sciences at Merck and Co., Inc., leading a group responsible for drug product design and early development across disease areas and drug modalities, including oligonucleotide therapeutics and mRNA vaccines. Previously, Dr. Gindy served as Director and Head of Sterile Product Development at Merck with responsibility for design and definition of formulation and manufacturing processes for Merck’s small molecule and peptide parenteral products, from preclinical stages to Phase 3 development. Marian also served as Strategy Lead for Merck’s implant product portfolio, leading conception of new products in Infectious Diseases and managing teams responsible for product design, preclinical feasibility and clinical translation.
Earlier, Dr. Gindy was the Director and Head of RNA Therapeutics Formulation Sciences at Merck, where she led the discovery and development of specialty formulation, drug delivery and manufacturing technologies for Merck’s siRNA therapeutics pipeline. Marian has also held leadership roles in drug substance process development and pilot plant operations. Her prior positions include tenure in the Chemical Engineering R&D and the Chemical Process and Development Commercialization groups at Merck.
Dr. Gindy received her Ph.D. in Chemical and Biological Engineering from Princeton University. She is the author of numerous scientific publications, patents and presentations on topics in pharmaceutical research, engineering, nanomedicine, drug delivery, and materials science.